drugset / Trial / NCT05482698
The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to access the efficacy and safety of MC2-25 cream and MC2-25 vehicle for treatment of chronic kidney disease associated pruritus (CKD)-aP).
Timeline
- Start
- 2022-07-01
- Primary completion
- 2024-02-02
- Completion
- 2024-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MC2-25 | Unknown | — | Topical |